| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,913,000 | 4,727,000 | 4,493,000 | 4,597,900 | | Cost of Revenue | 3,186,000 | 3,154,000 | 3,039,000 | 3,143,300 | | | Gross Profit | 1,727,000 | 1,573,000 | 1,454,000 | 1,454,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 856,000 | 964,000 | 826,000 | 811,300 | | Non Recurring |
-
|
-
|
-
| 20,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 871,000 | 609,000 | 628,000 | 623,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,000 | 6,000 | 8,000 | 15,400 | | Earnings Before Interest And Taxes | 878,000 | 615,000 | 636,000 | 638,700 | | Interest Expense | 67,000 | 71,000 | 73,000 | 81,000 | | Income Before Tax | 811,000 | 544,000 | 563,000 | 557,700 | | Income Tax Expense | 240,000 | 158,000 | 164,000 | 124,300 | | Minority Interest |
-
|
-
|
-
| (35,300) | | | | Net Income From Continuing Ops | 611,000 | 430,000 | 431,000 | 419,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| (300) | | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 531,000 | 430,000 | 431,000 | 419,300 | | Preferred Stock And Other Adjustments | 51,000 | (27,000) | (24,000) |
-
| | | Net Income Applicable To Common Shares | $582,000 | $403,000 | $407,000 | $419,300 |
|
0.50% Nasdaq 
0.79 (1.22%) 
Income Statement
